Inhibition of the insulin-like growth factor receptor-1 tyrosine kinase activity as a therapeutic strategy for multiple myeloma, other hematologic malignancies, and solid tumors
Constantine S. Mitsiades(Dana-Farber Cancer Institute), Nicholas Mitsiades(Beth Israel Deaconess Medical Center), Ciaran J. McMullan(Dana-Farber Cancer Institute), Vassiliki Poulaki(Massachusetts Eye and Ear Infirmary), Reshma Shringarpure(Harvard University), Masaharu Akiyama(Harvard University), Teru Hideshima(Dana-Farber Cancer Institute), Dharminder Chauhan(Harvard University), Marie Joseph(Harvard University), Towia A. Libermann(Beth Israel Deaconess Medical Center), Carlos Garcı́a-Echeverrı́a(Novartis (Switzerland)), Mark Pearson(Novartis (Switzerland)), Francesco Hofmann(Novartis (Switzerland)), Kenneth C. Anderson(Harvard University), Andrew L. Kung(Dana-Farber Cancer Institute)
Cited by 610
Abstract
Related Papers
No related papers found
Powered by citation graph analysis